Background: The factors affecting the prolonged air leak (PAL) and expansion failure in the lung in patients undergoing resection for lung malignancy were analyzed. In this context, the value of the percentage of low attenuation area (LAA%) measured on preoperative quantitative chest computed tomography (Q-: CT) in predicting the development of postoperative PAL and the expansion time of the remaining lung (ET) in patients undergoing resection for lung malignancy was investigated.
Methods: The data of 202 cases who underwent lung resection between July 2020 and December 2022 were analyzed.
Cystic fibrosis patients may be considered for lung transplantation. Although these patients may experience more successful outcomes and survival rates compared to others, various complications can arise. In particular, infectious complications and septic deaths may be more prevalent in cystic fibrosis patients compared to other lung transplant indications.
View Article and Find Full Text PDFBackground Thoracic surgery patients face unique postoperative challenges, particularly those undergoing lung resections. This study aimed to identify common complications and their management within the 30-day postoperative period, as well as investigate the relationship between early postoperative complications and unplanned outpatient follow-ups. Methods A retrospective analysis was conducted on 947 patients who underwent thoracic surgery between January 2020 and December 2023.
View Article and Find Full Text PDFBackground: To examine the effectiveness of 3D (dimensional)-vestibular rehabilitation therapy (VRT) on gait, balance problems, processing time speed and subjective complaints in patients with Benign Paroxysmal Positional Vertigo (BPPV) compared to a control group (CG). This study aimed to test the feasibility of virtual reality-based 3D exergaming conjunction with vestibular rehabilitation.
Methods: Twenty-two patients with BPPV (negative DixHallpike/Roll test results, existing dizziness/balance complaints) were randomly allocated to the study group (SG, n:11 3D-VRT) or Control group (CG n:11, no exercise-rehabilitation) for 8 week.